Preoperative Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Stage I-III Gastric Cancer Patients with a MGC Component

Figure 2

Kaplan-Meier analysis of OS for patients with gastric cancer with opposite PLR: (a) of younger age (<59 years) group; (b) of older age (≥59 years) group; (c) at TNM stage I+II; (d) at TNM stage III; (e) in total gastrectomy resection group; (f) in nontotal gastrectomy resection group.

(a)

(b)

(c)

(d)

(e)

(f)